COVID-19 and acute kidney injury in pediatric subjects: is there a place for eculizumab treatment?

J Nephrol. 2020 Dec;33(6):1119-1120. doi: 10.1007/s40620-020-00859-1.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Acute Kidney Injury* / chemically induced
  • Acute Kidney Injury* / diagnosis
  • Antibodies, Monoclonal, Humanized
  • Atypical Hemolytic Uremic Syndrome*
  • COVID-19*
  • Child
  • Humans
  • Pandemics
  • Patients
  • SARS-CoV-2

Substances

  • Antibodies, Monoclonal, Humanized
  • eculizumab